The Recall Desk

Manufacturer

Baxter Healthcare Corporation

439 recalls in our database name Baxter Healthcare Corporation as the manufacturing or recalling firm.

What the numbers show

Total
439
Critical
10
Severe
100
Most recent
2026-10-21

Of the 439 recalls from Baxter Healthcare Corporation we have scored against our rubric, 10 (2%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 100 (23%) are Severe.

Which agencies issued them

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–25 of 439

  • HighFDA (Devices)·Z-0151-2027·2026-10-21

    Baxter Recalls Likorall Overhead Lifts Due to Motor Shaft Breakage Risk

    Baxter Healthcare is recalling Likorall Overhead Lifts because a motor shaft breakage combined with reduced safety system performance may cause the lift strap to lower quickly, posing a risk of patient injury.

    Product
    Likorall Overhead Lifts Product Code: 3121001 Product Description: LIKORALL 200 Product Code: 3122005 Product Description: LIKORALL 242 ES, NATURAL Product Code: 3122005NA Product Description: LIKORALL 242 ES, NATURAL Product Code: 3122006 Product Description…
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-3264-2026·2026-09-30

    Baxter PRO+ Mattress Recalled for UDI Labeling Error

    Baxter Healthcare is recalling six PRO+ 40-inch MRS Surface mattresses due to errors in the Unique Device Identification (UDI) label text.

    Product
    PRO+ 40" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned, Model/Catalog Number: P7924A14
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-3257-2026·2026-09-30

    Baxter Recalls Two VOLARA Systems Due to Potential Flow Rate Inaccuracy

    Baxter Healthcare is recalling two VOLARA systems because contamination in test equipment may have affected flow rate accuracy. Affected devices were returned and confirmed to meet specifications.

    Product
    Brand Name: VOLARA System Product Name: VOLARA, HC, NA A Model/Catalog Number: M08594A Software Version: N/A Product Description: VOLARA, HOMECARE, NORTH AMERICA Component: No
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-3262-2026·2026-09-30

    Baxter Recalls PRO+ MRS Mattress Due to UDI Labeling Error

    Baxter Healthcare is recalling 169 PRO+ MRS Mattresses because UDI label errors may lead to incorrect product identification or use with incompatible bed frames.

    Product
    PRO+ MRS SURFACE FOR VERSACARE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned, Model/Catalog Number: P3255A08
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • ModerateFDA (Devices)·Z-3263-2026·2026-09-30

    Baxter PRO+ 36-inch Mattress Recalled for UDI Labeling Error

    Baxter Healthcare is recalling 824 PRO+ 36-inch MRS Surface mattresses due to errors in the Unique Device Identification (UDI) label. The discrepancies may lead to incorrect product identification or use with incompatible bed frames.

    Product
    PRO+ 36" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned, Model/Catalog Number: P7924A13
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0850-2026·2026-09-16

    Baxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter

    Baxter Healthcare is recalling 606 bags of Dextrose Injection, USP, 70% due to the presence of stainless steel particles in the solution.

    Product
    Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0819-2026·2026-09-09

    Baxter Recalls Vasopressin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Vasopressin in 0.9% Sodium Chloride Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    VASOPRESSIN IN 0.9% SODIUM CHLORIDE — VASOPRESSIN IN 0.9% SODIUM CHLORIDE (VASOPRESSIN IN 0.9% SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0809-2026·2026-09-09

    Baxter Recalls Famotidine Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Famotidine Injection due to CGMP deviations. The product was distributed in the US, Puerto Rico, and Chile.

    Product
    FAMOTIDINE — FAMOTIDINE (FAMOTIDINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0810-2026·2026-09-09

    Baxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Dexmedetomidine Hydrochloride Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-9557-12.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0821-2026·2026-09-09

    Baxter Recalls Daptomycin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Daptomycin Injection due to Current Good Manufacturing Practice (CGMP) deviations. The recall covers the US, Puerto Rico, and Chile.

    Product
    Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0817-2026·2026-09-09

    Baxter Recalls Clindamycin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to CGMP deviations. The affected product was distributed in the US, Puerto Rico, and Chile.

    Product
    CLINDAMYCIN PHOSPHATE — CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0820-2026·2026-09-09

    Baxter Recalls Vancomycin Injection Due to CGMP Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Vancomycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    VANCOMYCIN HYDROCHLORIDE — VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0814-2026·2026-09-09

    Baxter Recalls Nexterone Amiodarone Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Nexterone (amiodarone hydrochloride) injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    NEXTERONE — NEXTERONE (AMIODARONE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0808-2026·2026-09-09

    Baxter Recalls Clindamycin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    CLINDAMYCIN PHOSPHATE — CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0807-2026·2026-09-09

    Baxter Recalls Daptomycin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling Daptomycin in Sodium Chloride Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0805-2026·2026-09-09

    Baxter Recalls Vancomycin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Vancomycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    VANCOMYCIN HYDROCHLORIDE — VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-3066-2026·2026-09-09

    Baxter Novum IQ Syringe Pump Recalled for Software Infusion Issue

    Baxter Healthcare is recalling four Novum IQ Syringe Pump loaner units due to a software issue that may occur during multi-syringe infusions.

    Product
    Baxter Novum IQ Syringe Pump, Loaner, Model Number 40800BAXUSL
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0815-2026·2026-09-09

    Baxter Recalls Clindamycin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    CLINDAMYCIN PHOSPHATE — CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-3065-2026·2026-09-09

    Baxter Novum IQ Syringe Pump Software Issue Recall

    Baxter Healthcare is recalling 14,601 Novum IQ Syringe Pumps due to a software issue that may occur during multi-syringe infusions.

    Product
    Baxter Novum IQ Syringe Pump, Model Number 40800BAXUS
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0813-2026·2026-09-09

    Baxter Recalls CARDENE IV Nicardipine Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of CARDENE IV (Nicardipine Hydrochloride) injection due to CGMP deviations. The recall covers products distributed in the US, Puerto Rico, and Chile.

    Product
    CARDENE IV — CARDENE IV (NICARDIPINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0811-2026·2026-09-09

    Baxter Recalls Vasopressin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Vasopressin in 0.9% Sodium Chloride Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    VASOPRESSIN IN 0.9% SODIUM CHLORIDE — VASOPRESSIN IN 0.9% SODIUM CHLORIDE (VASOPRESSIN IN 0.9% SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0818-2026·2026-09-09

    Baxter Recalls Clindamycin Injection Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling specific lots of Clindamycin Injection due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    CLINDAMYCIN PHOSPHATE — CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0806-2026·2026-09-09

    Baxter Recalls MYXREDLIN Insulin Due to Manufacturing Deviations

    Baxter Healthcare is voluntarily recalling MYXREDLIN insulin due to CGMP deviations. The recall covers specific lots distributed in the US, Puerto Rico, and Chile.

    Product
    MYXREDLIN — MYXREDLIN (INSULIN HUMAN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0816-2026·2026-09-09

    Baxter Recalls Clindamycin Phosphate Injection Due to CGMP Deviations

    Baxter Healthcare is voluntarily recalling Clindamycin Phosphate Injection due to Current Good Manufacturing Practice (CGMP) deviations. The affected product was distributed in the US, Puerto Rico, and Chile.

    Product
    CLINDAMYCIN PHOSPHATE — CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Baxter Healthcare Corporation

business enterprise in United States of America

Country
United States

Source: Wikidata (Q45134864), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.